Development of a cardiomyopathy in a model of noninsulin-dependent diabetes

Am J Physiol. 1985 Feb;248(2 Pt 2):H179-85. doi: 10.1152/ajpheart.1985.248.2.H179.

Abstract

Wistar rats were injected with streptozotocin (SZ) at 3 days of age. This maneuver produced a marked glucose intolerance, as determined by intraperitoneal glucose tolerance tests, but plasma fasting and nonfasting glucose values remained at or near normal throughout the 12-mo study period. Hearts obtained from these glucose-intolerant rats exhibited a progressive cardiomyopathy that consisted of both contractile and metabolic abnormalities. Contractile abnormalities were characterized by reductions in aortic output, ventricular pressure, and cardiac work. Associated with these mechanical defects was a decrease in glucose utilization. These abnormalities were not ameliorated by acute exposure to insulin or changes in the work load of the heart. These results demonstrate that, in the rat, a progressive cardiomyopathy results from persistent glucose intolerance in the absence of fasting hyperglycemia. This cardiomyopathy is reminiscent of that described in human noninsulin-dependent diabetes.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cardiomyopathies / etiology*
  • Cardiomyopathies / physiopathology
  • Diabetes Mellitus, Experimental / complications*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Glucose / metabolism
  • Insulin / pharmacology
  • Male
  • Rats
  • Rats, Inbred Strains
  • Streptozocin

Substances

  • Insulin
  • Streptozocin
  • Glucose